Week In Review: Yantai's MabPlex Raises $59 Million To Expand CDMO Services
January 20, 2019 at 10:38 AM EST
MabPlex, a biologics CDMO, raised $59 million in a Series A round from SDIC Venture Fund and Shenzhen Venture Capital. MabPlex offers biologics development and manufacturing services, including mAbs, recombinant proteins, ADCs and bispecifics.
